[vc_row][vc_column width="2/3"][vc_column_text css=""]Victoria Crawford has been a longtime supporter of the National Foundation for Cancer Research (NFCR). Having first been introduced to NFCR through her involvement with the annual Daffodils & Diamonds Fundraiser, Victoria’s connection with NFCR has grown over the years. From her zest for...
[vc_row][vc_column][vc_single_image image="69584" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Circulating tumor cells (CTCs) present a major problem for cancer treatment since they cause therapy resistance and metastasis, the main reasons for cancer-related deaths. By creating experimental models based on CTCs, it will be possible to study CTC biology and...
[vc_row css=".vc_custom_1783612939292{margin-top: 10px !important;margin-bottom: 20px !important;border-top-width: 4px !important;border-right-width: 4px !important;border-bottom-width: 4px !important;border-left-width: 4px !important;padding-top: 10px !important;padding-bottom: 10px !important;background-color: #FFFFFF !important;border-left-style: solid !important;border-right-style: solid !important;border-top-style: solid !important;border-bottom-style: solid !important;border-radius: 20px !important;border-color: #002C76 !important;}"][vc_column][vc_column_text css=".vc_custom_1785780278639{padding-right: 20px !important;padding-left: 20px !important;}"] Main Takeaways From This Episode: Tom Clark shares the story...
[vc_row][vc_column][vc_single_image image="69519" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] A group of researchers, whose work has been supported by the National Foundation for Cancer Research (NFCR), has created a powerful piece of software that allows scientists to model tumor growth, immune responses, and treatment outcomes in a virtual environment. The...
[vc_row][vc_column][vc_single_image image="69243" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Glioblastoma (GBM) is the most aggressive form of brain cancer with a uniformly fatal diagnosis, limited treatment options, and a median survival of less than two years. Although chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized the treatment of certain cancers,...
[vc_row css=".vc_custom_1783612939292{margin-top: 10px !important;margin-bottom: 20px !important;border-top-width: 4px !important;border-right-width: 4px !important;border-bottom-width: 4px !important;border-left-width: 4px !important;padding-top: 10px !important;padding-bottom: 10px !important;background-color: #FFFFFF !important;border-left-style: solid !important;border-right-style: solid !important;border-top-style: solid !important;border-bottom-style: solid !important;border-radius: 20px !important;border-color: #002C76 !important;}"][vc_column][vc_column_text css=""] Main Takeaways From This Episode: 1. Melanoma is often silent until it's advanced. Unlike many...
[vc_row][vc_column][vc_column_text css=""] #ASCO26: Where Tomorrow’s Cancer Breakthroughs Take the Spotlight The 2026 ASCO Annual Meeting starts this Friday, May 29, in Chicago. This event features new research and updates from top experts. The work presented at this meeting will lay the foundation for how cancer care can...
[vc_row][vc_column][vc_column_text css=""]Rockville, MD — The National Foundation for Cancer Research (NFCR) is proud to announce that Dr. Michele Carbone of the University of Hawaii Cancer Center is the recipient of the 2026 Szent-Györgyi Prize for Progress in Cancer Research.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width="2/3"][vc_column_text css=""]Dr. Michele Carbone receives the...
[vc_row][vc_column][vc_empty_space][vc_raw_html css=""]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[/vc_raw_html][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Back in 1979, a scientist made an accidental discovery involving a simple tumor virus. That breakthrough eventually led to more than 80 FDA-approved cancer drugs used around the world today. That scientist is Dr. Tony Hunter. In the latest episode of All Things Cancer,...
[vc_row][vc_column][vc_column_text css=""]At the 2026 AACR Annual Meeting, NFCR-supported scientists shared impactful discoveries shaping the future of cancer prevention, diagnosis, and treatment. From cutting-edge clinical trials to breakthroughs in tumor biology and artificial intelligence, NFCR-funded researchers are helping advance promising science toward lifesaving cures. Highlights from NFCR-supported scientists...
Search NFCR
Popular searches